Surfactant protein a suppresses lipopolysaccharide-induced IL-10 production by murine macrophages

Journal of Immunology

Volumn 166, Issue 10, 2001, Pages 6376-6382

  Salez, Laurent ^a   Balloy, Viviane ^a   Van Rooijen, Nico ^b   Lebastard, Mai ^a   Touqui, Lhousseine ^a   McCormack, Francis X ^c   Chignard, Michel ^a  

^a INSTITUT PASTEUR   (France)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; LIPOSOME; SURFACTANT PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; LUNG ALVEOLUS MACROPHAGE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

EID: 0035873438     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.10.6376     Document Type: Article

References (54)

1. Meduri, G. U. 1996. The role of the host defense response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur. Respir. J. 9:2650.
2. Pillet, J. F., R. C. Mackersie, T. R. Martin, and M. A. Matthay. 1997. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. 155:1187.
3. Brigham, K. L., and B. Meyrick. 1986. Endotoxin and lung injury. Am. Rev. Respir. Dis. 133:931.
4. Tracey, K. J., and A. Cerami. 1993. Tumor necrosis factor: an updated review of its biology. Crit. Care Med. 21:S415.
5. Strieter, R. M., S. L. Kunkel, and R. C. Bone. 1993. Role of tumor necrosis factor-α in disease states and inflammation. Crit. Care Med. 21:S447.
6. 2. J. Exp. Med. 180: 2365.
7. Platzer, C., C. Meisel, K. Vogt, M. Platzer, and H. D. Volk. 1995. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7:517.
8. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
9. Lalani, I., K. Bohl, and A. R. Ahmed. 1997. Interleukin-10: biology, role in inflammation and autoimmunity. Ann. Allergy Asthma Immunol. 79:469.
10. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Imumunol. 147: 3815.
11. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin-10. J. Exp. Med. 174:1549.
12. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
13. Rogy, M. A., T. Auffenberg, N. J. Espat, R. Philip, D. Remick, G. K. Vollenberg, E. M. Copeland III, and L. L. Moldawer. 1995. Human tumor necrosis factor receptor (p55) and interleukin-10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J. Exp. Med. 181:2289.
14. Pajkrt, D., L. Camoglio, M. C. M. Tiel-van Buul, K. de Bruin, D. L. Cutler, M. B. Affrime, G. Rikken, T. van der Poll, J. W. ten Cate, and S. J. H. van Deventer. 1997. Attenuation of proinflammatory response by recombinant human IL-10, in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158:3971.
15. Salez, L., M. Singer, V. Balloy, C. Créminon, and M. Chignard. 2000. Lack of IL-10 synthesis by murine alveolar macrophages upon lipopolysaccharide exposure: comparison with peritoneal macrophages. J. Leukocyte Biol. 67:545.
16. Wright, J. R. 1997. Immunomodulatory functions of surfactant. Physiol. Rev. 77:931.
17. Clark, H. W., K. B. M. Reid, and R. B. Sim. 2000. Collectins and innate immunity in the lung. Infect. Immun. 2:273.
18. Crouch, E., K. Hartshorn, and I. Ofek. 2000. Collectins and pulmonary innate immunity. Immunol. Rev. 173:52.
19. van Iwaarden, F., B. Welmers, J. Verhoef, H. P. Haagsman, and L. M. van Golde. 1990. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 2:91.
20. Weisshach, S., A. Neuendank, M. Pettersson, T. Schaberg, and U. Pison. 1994. Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages. Am. J. Physiol. 267:L660.
21. Katsura, H., H. Kawada, and K. Konno. 1993. Rat surfactant apoprotein A (SP-A) exhibits antioxidant effects on alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 9:520.
22. Kalina, M., S. Riklis, and H. Blau. 1997. Surfactant protein A and lipids modulate nitric oxide production by alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 155:A215.
23. Pasula, R., J. R. Wright, D. L. Kachel, and W. J. Martin III. 1999. Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J. Clin. Invest. 103:483.
24. McIntosh, J. C., S. Mervin-Blake, E. Conner, and J. R. Wright. 1996. Surfactant protein A protects growing cells and reduces TNF-α activity from LPS-stimulated macrophages. Am. J. Physiol. 271:L310.
25. Kremlev, S. G., T. M. Umstead, and D. S. Phelps. 1997. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1. Am. J. Physiol. 272:L996.
26. Sano, H., H. Sohma, T. Muta, S. Nomura, D. R. Voelker, and Y. Kuroki. 1999. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J. Immunol. 163:387.
27. Pikaar, J. C., W. F. Voorhout, L. M. G. van Golde, J. Verhoef, J. A.G. van Strijp,. and F. van Iwaarden. 1995. Opsonic activities of surfactant protein A and D in phagocytosis of Gram-negative bacteria by alveolar macrophages. J. Infect. Dis. 172:481.
28. Tino, M. J., and J. R. Wright. 1996. Surfactant protein A stimulates the phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am. J. Physiol. 270:L677.
29. Van Iwaarden, J. F., J. A. G. van Strijp, M. J. M. Ebskamp, A. C. Welmers, J. Verhoef, and L. M. G. van Golde. 1991. Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am. J. Physiol. 261:L204.
30. Zimmerman, P. E., D. R. Voelker, F. X. McCormack, J. R. Paulsrud, and W. J. Martin. 1992. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J. Clin. Invest. 89:143.
31. Mariencheck, W. I., J. Savov, Q. Dong, M. J. Tino, and J. R. Wright. 1999. Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am. J. Physiol. 277:L777.
32. Koziel, H., D. S. Phelps, J. A. Fishman, M. Y. Armstrong, F. F. Richards, and R. M. Rose. 1998. Surfactant protein-A reduces binding and phagocytosis of Pneumocystis carinii by human alveolar macrophages in vitro. Am. J. Respir. Cell Mol. Biol. 18:834.
33. Walenkamp, A. M., A. F. Verheul, J. Scharringa, and I. M. Hoepelman. 1999. Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis. Eur. J. Clin. Invest. 29:83.
34. Suwabe, A., R. J. Mason, and D. R. Voelker. 1996. Calcium dependent association of surfactant protein A with pulmonary surfactant: application to simple surfactant protein A purification. Arch. Biochem. Biophys. 327:285.
35. Pradelles, P., J. Grassi, C. Creminon, B. Boutten, and S. Mamas. 1994. Immunometric assay of low molecular weight haptens containing primary amino groups. Anal. Chem. 66:16.
36. Etienne, E., C. Creminon, J. Grassi, D. Grouselle, J. Roland, and P. Pradelles. 1996. Enzyme immunometric assay of thyroliberin (TRH). J. Immunol. Methods 198:79.
37. Grassi, J., Y. Frobert, P. Pradelles, F. Chercuitte, D. Gruaz, J. M. Dayer, and P. E. Poubelle. 1989. Production of monoclonal antibodies against interleukin-1 α and -1β: development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J. Immunol. Methods 123:193.
38. Pradelles, P., J. Grassi, and J. Maclouf. 1985. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal. Chem. 57:1170.
39. Abrams, J. S., M. G. Roncarolo, H. Yssel, U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
40. Stanley, E. R., and P. M. Heard. 1977. Factors regulating macrophage production and growth: purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J. Biol. Chem. 252:4305.
41. Van Rooijen. N. 1989. The liposome mediated macrophage "suicide" technique. J. Immunol. Methods 124:1.
42. Thepen, T., N. van Rooijen, and G. Kraal. 1989. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 170:499.
43. Frankenberger, M., H. Pechumer, and H. W. L. Ziegler-Heitbrock. 1995. Interieukin-10 is upregulated in LPS tolerance. J. Inflamm. 45:56.
44. Li, X. C., M. Miyasaka, and T. B. Issekutz. 1998. Blood monocyte migration to acute lung inflammation involves both CD11/CD18 and very late activation antigen-4-dependent and independent pathways. J. Immunol. 161:6258.
45. Hashimoto, S., J. F. Pittet, K. Hong, H. Folkesson, G. Bagby, L. Kobzik, C. Frevert, K. Watanabe, S. Tsurufuji, and J. Wiener-Kronish. 1996. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. Am. J. Physiol. 270:L819.
46. Kooguchi, K., S. Hashimoto, A. Kobayashi, Y. Kitamura, I. Kudoh, J. Wiener-Kronish, and T. Sawa. 1998. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun. 66:3164.
47. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319.
48. van Oud Alblas, A. B., and R. van Furth. 1979. Origin, kinetics, and characteristics of pulmonary macrophages in the normal steady state. J. Exp. Med. 149: 1504.
49. Valledor, A. F., F. E. Borras, M. Cullell-Young, and A. Celada. 1998. Transcription factors that regulate monocyte/macrophage differentiation. J. Leukocyte Biol. 63:405.
50. Toosi, Z., C. S. Hirsch, B. D. Hamilton, C. K. Knuth, M. A. Friedlander, and E. A. Rich. 1996. Decreased production of TGF-β1 by human alveolar macrophages compared with blood monocytes. J. Immunol. 156:3461.
51. Chroneos, Z., and V. L. Shepherd. 1995. Differential regulation of the mannose and SP-A receptors on macrophages. Am. J. Physiol. 269:L721.
52. Geertsma, M. F., W. L. Teew, P. H. Nibbering, and R. van Furth. 1994. Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-γ. Immunology 82:450.
53. Bondeson, J., K. A. Browne, F. M. Brennan, B. M. Foxwell, and M. Feldmann. 1999. Selective regulation of cytokine induction of adenoviral gene transfer of Iκ-B α into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is not nuclear factor-κB independent. J. Immunol. 162:2939.
54. Brightbill, H. D., S. E. Plevy, R. L. Modlin, and S. T. Smale. 1999. A prominent role for Sp1 lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 164:1940.